Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 651–656 of 656 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00741247	Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA	completed	N/A	150	National Cancer Center, KoreaOTHER_GOV	1	Jun 24, 2009	clinicaltrials
NCT00579215	Lung Cancer Informational Study (LCIS)	completed	N/A	8	Memorial Sloan Kettering Cancer CenterOTHER	1	Mar 18, 2009	clinicaltrials
NCT00398970